ATR inhibition broadly sensitizes ovarian cancer cells to chemotherapy independent of BRCA status

Catherine J. Huntoon, Karen S. Flatten, Andrea E. Wahner Hendrickson, Amelia M. Huehls, Shari L. Sutor, Scott H. Kaufmann, Larry M. Karnitz

Research output: Contribution to journalArticlepeer-review

112 Scopus citations

Fingerprint Dive into the research topics of 'ATR inhibition broadly sensitizes ovarian cancer cells to chemotherapy independent of BRCA status'. Together they form a unique fingerprint.

Medicine & Life Sciences